Form 4: Thomas F. Frist III Receives HCA Equity Award

Director Thomas F. Frist III acquired 1,041 restricted share units as part of his annual director compensation package.

Summary

• Thomas F. Frist III, a director and 10% owner of HCA Healthcare, Inc., was granted 1,041 restricted share units (RSUs) on April 28, 2026.
• The grant consists of 509 RSUs for the annual director equity award and 532 RSUs received in lieu of annual cash retainers for his service as a director and Chairman of the Board.
• The RSUs vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.
• Vested shares will be delivered to the reporting person upon his departure from the Board of Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• The transaction reflects alignment between the Chairman of the Board and long-term shareholder interests through equity-based compensation.
• The reporting person continues to maintain significant indirect beneficial ownership in the company through Frisco Holding II and Hercules Holding II.

Negatives

• None identified; this is a standard director compensation disclosure.

Risks

• The value of the equity award is subject to market fluctuations in HCA Healthcare, Inc. common stock.

Future Outlook

The RSUs are scheduled to vest in 2027, with delivery of shares deferred until the director leaves the Board.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of director compensation, which is standard practice for large-cap healthcare providers to ensure board alignment with corporate performance.

Comparison to Industry Standards

• The use of equity-based compensation for board members is consistent with governance practices at major healthcare peers like Tenet Healthcare and Universal Health Services.
• The deferral of share delivery until board departure is a common mechanism to encourage long-term oversight.

Related Party Transactions

• The reporting person is associated with Frisco Holding II and Hercules Holding II, which hold significant stakes in HCA Healthcare, Inc.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 1,041 RSUs at the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Key Dates

Keywords

HCA Healthcare, Form 4, Director Compensation, Insider Ownership, Equity Award, Thomas F. Frist III